Largest biotech by market cap
CRISPR Therapeutics has the lowest figure of the 24 biotech ranked by market value, at SEK 39.6B, followed by Adaptive Biotechnologies (SEK 46.9B) and Scholar Rock Holding (SEK 55.9B). Figures as of 18 Nov 2026, 12:59 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- CRISPR TherapeuticsSEK 39.6B
- Median
- SEK 105.4B
- Combined market value
- SEK 8.63T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Market cap ↑ | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|
| 1 | CRISPR TherapeuticsCRSP · Health Care | SEK 39.6B | SEK 408.01 | 0.54% down | 21% down | ||
| 2 | Adaptive BiotechnologiesADPT · Health Care | SEK 46.9B | SEK 289.52 | 2.22% up | 88% up | ||
| 3 | Scholar Rock HoldingSRRK · Health Care | SEK 55.9B | SEK 458.11 | 1.21% up | 14% up | ||
| 4 | Kodiak SciencesKOD · Health Care | SEK 64.3B | SEK 983.70 | 3.90% down | 396% up | ||
| 5 | ImmunityBioIBRX · Health Care | SEK 67.7B | SEK 63.61 | 4.68% up | 193% up | ||
| 6 | ImmunovantIMVT · Health Care | SEK 69.8B | SEK 337.48 | 0.21% down | 43% up | ||
| 7 | CG OncologyCGON · Health Care | SEK 71.7B | SEK 802.20 | 6.89% down | 85% up | ||
| 8 | Twist BioscienceTWST · Health Care | SEK 77.6B | SEK 1,138.16 | 6.63% up | 340% up | ||
| 9 | Krystal BiotechKRYS · Health Care | SEK 89.9B | SEK 3,033.91 | 0.22% up | 46% up | ||
| 10 | VaxcytePCVX · Health Care | SEK 95.6B | SEK 603.63 | 3.59% down | 22% up | ||
| 11 | QiagenQGEN · Health Care | SEK 104.4B | SEK 505.57 | 0.12% down | 12% up | ||
| 12 | RepligenRGEN · Health Care | SEK 105.4B | SEK 1,648.10 | 0.37% down | 5% up | ||
| 13 | Kymera TherapeuticsKYMR · Health Care | SEK 105.4B | SEK 1,234.90 | 3.44% down | 87% up | ||
| 14 | Halozyme TherapeuticsHALO · Health Care | SEK 111.2B | SEK 975.26 | 0.55% down | 37% up | ||
| 15 | Bio-TechneTECH · Health Care | SEK 115.9B | SEK 738.08 | 0.22% down | 26% up | ||
| 16 | ExelixisEXEL · Health Care | SEK 169.9B | SEK 696.11 | 2.09% up | 63% up | ||
| 17 | Neurocrine BiosciencesNBIX · Health Care | SEK 170.7B | SEK 1,686.10 | 0.37% up | 20% up | ||
| 18 | BioNTechBNTX · Health Care | SEK 213.8B | SEK 862.36 | 0.47% down | 16% down | ||
| 19 | Revolution MedicinesRVMD · Health Care | SEK 357.6B | SEK 1,653.28 | 2.50% down | 131% up | ||
| 20 | BiogenBIIB · Health Care | SEK 376.7B | SEK 2,548.56 | 0.34% down | 49% up | ||
| 21 | argenxARGX · Health Care | SEK 605.5B | SEK 9,628.83 | 0.36% down | 4% up | ||
| 22 | ModernaMRNA · Health Care | SEK 850.3B | SEK 2,101.53 | 3.93% down | 755% up | ||
| 23 | Gilead SciencesGILD · Health Care | SEK 2.15T | SEK 1,730.21 | 1.60% up | 33% up | ||
| 24 | AmgenAMGN · Health Care | SEK 2.52T | SEK 4,653.55 | 0.95% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1621 SEK).
Questions and answers
Which biotech have the lowest market cap?
CRISPR Therapeutics (SEK 39.6B), Adaptive Biotechnologies (SEK 46.9B) and Scholar Rock Holding (SEK 55.9B) have the lowest market cap of the 24 biotech ranked here as of 18 Nov 2026, 12:59 UTC.
How many biotech are in this ranking?
24 are ranked by market value.
What are these biotech worth together?
The 24 biotech ranked by market value have a combined market value of SEK 8.63T as of 18 Nov 2026, 12:59 UTC.
What does ranking by market value measure?
What the stock market values the whole company at: its share price times the number of its shares.
Learn how this ranking works
All markets guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech by market cap”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech
Underlying data: Yahoo Finance; SEC EDGAR.